Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)-;two related blood diseases that disproportionally strike older adults-;are notoriously difficult to treat and associated with high relapse rates.
FDA awards grant for phase 1 clinical trial of experimental AML/MDS treatment
- Post author:
- Post published:November 28, 2023
- Post category:uncategorized